TechCrunch @TechCrunch
Frequency Therapeutics redesigns study after disappointing Phase 2 results, debuts new hearing loss and MS drugs https://t.co/L3QiEE7mJB by @emmakbetuel — PolitiTweet.org
Created
Tue Nov 09 15:19:53 +0000 2021
Likes
20
Retweets
6
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
TechCrunch @TechCrunch
Frequency Therapeutics redesigns study after disappointing Phase 2 results, debuts new hearing loss and MS drugs https://t.co/L3QiEE7mJB by @emmakbetuel — PolitiTweet.org